The effect of caffeic acid phenethyl ester on QT interval in cirrhotic rats

HealthMED

Volumn 6, Issue 10, 2012, Pages 3281-3285

  Dianat, Mahin ^a   Fard, Samira Saadat ^a   Badavi, Mohammad ^a   Ahangarpour, Akram ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bazzet's formula; Caffeic acid phenethyl ester; Cirrhosis; QT prolongation; Rat

Indexed keywords

BILIRUBIN; CAFFEIC ACID PHENETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; MALE; NONHUMAN; QT INTERVAL; RAT;

EID: 84871226177     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Lee RF, Glenn TK, Lee SS. Cardiac dysfunction in cirrhosis. Best Practice & Research Clinical Gastroenterology. 2007; 21(1): 125-40.
2. Inserte J, Perelló A, Agulló L, Ruiz-Meana M, Schlüter K-D, Escalona N, et al. Left ventricular hypertrophy in rats with biliary cirrhosis. Hepatology. 2003; 38(3): 589-98.
3. Moller S, Henriksen JH. Cirrhotic cardiomyopathy: A pathophysiological review of circulatory dysfunction in liver disease. Heart. 2002; 87(1): 9-15.
4. Moller S, Henriksen JH. Cardiovascular complications of cirrhosis. Postgraduate Medical Journal. 2009; 85(999): 44-54.
5. Wong F. Cirrhotic cardiomyopathy. Hepatol Int. 2009 Mar; 3(1): 294-304.
6. Zambruni A, Trevisani F, Caraceni P, Bernardi M. Cardiac electrophysiological abnormalities in patients with cirrhosis. Journal of Hepatology. 2006; 44(5): 994-1002.
7. Møller S, Henriksen JH. Cirrhotic cardiomyopathy. Journal of Hepatology. 2010; 53(1): 179-90.
8. Torregrosa M, Aguadé S, Dos L, Segura R, Gónzalez A, Evangelista A, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. Journal of Hepatology. 2005; 42(1): 68-74.
9. Okutan H, Ozcelik N, Ramazan Yilmaz H, Uz E. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clinical Biochemistry. 2005; 38(2): 191-6.
10. Oktar S, Aydin M, Yonden Z, Alcin E, Ilhan S, Nacar A. Effects of caffeic acid phenethyl ester on isoproterenol-induced myocardial infarction in rats. Anadolu Kardiyol Derg. 2010; 10(4): 298-302.
11. Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C, et al. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res. 1999 May 15; 59(10): 2347-52.
12. Orban Z, Mitsiades N, Burke Jr TR, Tsokos M, Chrousos GP. Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation. NeuroImmuno-Modulation. 2000; 7(2): 99-105.
13. Chen YJ, Shiao MS, Wang SY. The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anticancer Drugs. 2001 Feb; 12(2): 143-9.
14. N. Orsolic ST, Z. Mihaljevic, L. Sver and I. Basic. Effects of local administration of propolis and its polyphenolic compounds on tumor formation and growth. Biological and Pharmaceutical Bulletin. 2005; 28(10): 1928-33.
15. Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J, Kohn KW. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochemical Pharmacology. 1994; 48(3): 595-608.
16. Park EH, Kahng JH. Suppressive effects of propolis in rat adjuvant arthritis. Archives of Pharmacal Research. 1999; 22(6): 554-8.
17. Albukhari AA, Gashlan HM, El-Beshbishy HA, Nagy AA, Abdel-Naim AB. Caffeic acid phenethyl ester protects against tamoxifen-induced hepatotoxicity in rats. Food and Chemical Toxicology. 2009; 47(7): 1689-95.
18. Wu W-M, Lu L, Long Y, Wang T, Liu L, Chen Q, et al. Free radical scavenging and antioxidative activities of caffeic acid phenethyl ester (CAPE) and its related compounds in solution and membranes: A structure-activity insight. Food Chemistry. 2007; 105(1): 107-15.
19. Lee KJ, Choi JH, Khanal T, Hwang YP, Chung YC, Jeong HG. Protective effect of caffeic acid phenethyl ester against carbon tetrachloride-induced hepatotoxi city in mice. Toxicology. 2008 Jun 3; 248(1): 18-24.
20. Ogeturk M, Kus I, Colakoglu N, Zararsiz I, Ilhan N, Sarsilmaz M. Caffeic acid phenethyl ester protects kidneys against carbon tetrachloride toxicity in rats. J Ethnopharmacol. 2005 Feb 28; 97(2): 273-80.
21. Mollaoglu H, Gokcimen A, Ozguner F, Oktem F, Koyu A, Kocak A, et al. Caffeic acid phenethyl ester prevents cadmium-induced cardiac impairment in rat. Toxicology. 2006 Oct 3; 227(1/2): 15-20.
22. Fadillioglu E, Oztas E, Erdogan H, Yagmurca M, Sogut S, Ucar M, et al. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol. 2004 Jan-Feb; 24(1): 47-52.
23. Ilhan A, Koltuksuz U, Ozen S, Uz E, Ciralik H, Akyol O. The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. Eur J Cardiothorac Surg. 1999 Oct; 16(4): 458-63.
24. Huang SS, Liu SM, Lin SM, Liao PH, Lin RH, Chen YC, et al. Antiarrhythmic effect of caffeic acid phenethyl ester (CAPE) on myocardial ischemia/reperfusion injury in rats. Clin Biochem. 2005 Oct; 38(10): 943-7.
25. Russo A, Longo R, Vanella A. Antioxidant activity of propolis: Role of caffeic acid phenethyl ester and galangin. Fitoterapia. 2002; 73(SUPPL. 1).
26. Altug ME, Serarslan Y, Bal R, Kontas T, Ekici F, Melek IM, et al. Caffeic acid phenethyl ester protects rabbit brains against permanent focal ischemia by antioxidant action: A biochemical and planimetric study. Brain Research. 2008; 1201: 135-42.
27. Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Letters. 1993; 329(1/2): 21-4.
28. Rodriguez-Garay EA. Cholestasis: human disease and experimental animal models. Ann Hepatol. 2003 Oct-Dec; 2(4): 150-8.
29. Mitchell GF, Jeron A, Koren G. Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol. 1998 Mar; 274(3 Pt 2): H747-51.
30. Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra and extrahepatic cholestasis. J Clin Invest. 2003 Dec; 112(11): 1678-87.
31. Rivera-Huizar S, Rincn-Sanchez AR, Covarrubias-Pinedo A, Islas-Carbajal MC, Gabriel-Ortiz G, Pedraza-Chaverri J, et al. Renal dysfunction as a consequence of acute liver damage by bile duct ligation in cirrhotic rats. Experimental and Toxicologic Pathology. 2006; 58(2/3): 185-95.
32. Koyu A, Ozguner F, Yilmaz H, Uz E, Cesur G, Ozcelik N. The protective effect of caffeic acid phenethyl ester (CAPE) on oxidative stress in rat liver exposed to the 900 MHz electromagnetic field. Toxicol Ind Health. 2009 Jul; 25(6): 429-34.
33. Payabvash S, Kiumehr S, Nezami BG, Zandieh A, Anvari P, Tavangar SM, et al. Endogenous opioids modulate hepatocyte apoptosis in a rat model of chronic cholestasis: the role of oxidative stresss. Liver Int. 2007 May; 27(4): 538-47.
34. Ebrahimkhani MR, Moezi L, Kiani S, Merat S, Dehpour AR. Opioid receptor blockade improves mesenteric responsiveness in biliary cirrhosis. Dig Dis Sci. 2008 Nov; 53(11): 3007-11.
35. Lanjewar P, Pathak V, Lokhandwala Y. Issues in QT interval measurement. Indian Pacing Electrophysiol J. 2004; 4(4): 156-61.
36. Fernández-Martínez E, Pérez-Álvarez V, Tsutsumi V, Shibayama M, Muriel P. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat. Experimental and Toxicologic Pathology. 2006; 58(1): 49-58.
37. Coban S, Yildiz F, Terzi A, Al B, Ozgor D, Ara C, et al. The Effect of Caffeic Acid Phenethyl Ester (CAPE) Against Cholestatic Liver Injury in Rats. Journal of Surgical Research. 2008; 159(2): 674-9.
38. Kus I, Colakoglu N, Pekmez H, Seckin D, Ogeturk M, Sarsilmaz M. Protective effects of caffeic acid phenethyl ester (CAPE) on carbon tetrachlorideinduced hepatotoxicity in rats. Acta Histochemica. 2004; 106(4): 289-97.